aH5N6c
/ CSL Behring
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
November 27, 2024
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults
(clinicaltrials.gov)
- P2 | N=480 | Completed | Sponsor: Seqirus | Active, not recruiting ➔ Completed
Trial completion • Infectious Disease • Influenza • Respiratory Diseases
August 25, 2023
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults
(clinicaltrials.gov)
- P2 | N=480 | Active, not recruiting | Sponsor: Seqirus | Recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases
June 12, 2023
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults
(clinicaltrials.gov)
- P2 | N=480 | Recruiting | Sponsor: Seqirus | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Influenza • Respiratory Diseases
May 25, 2023
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults
(clinicaltrials.gov)
- P2 | N=480 | Not yet recruiting | Sponsor: Seqirus
New P2 trial • Infectious Disease • Influenza • Respiratory Diseases
April 14, 2023
A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed
(clinicaltrials.gov)
- P2 | N=260 | Completed | Sponsor: Seqirus | Active, not recruiting ➔ Completed
Trial completion • Infectious Disease • Influenza • Respiratory Diseases
October 12, 2022
A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed
(clinicaltrials.gov)
- P2 | N=260 | Active, not recruiting | Sponsor: Seqirus | Recruiting ➔ Active, not recruiting | Trial primary completion date: May 2023 ➔ Oct 2022
Enrollment closed • Preclinical • Trial primary completion date • Infectious Disease • Influenza • Respiratory Diseases
1 to 6
Of
6
Go to page
1